Kereos
Kereos | Targeted Therapeutics and Molecular Imaging.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD121—181m (Dealroom.co estimates Sep 2005.)
Saint-Louis Département de Saint-Louis (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Debt | ||
$19.5m | Series B | ||
| N/A | $887k | Debt | |
| N/A | $5.7m | Debt | |
| N/A | $1.1m | Debt | |
N/A | Debt | ||
N/A | Debt | ||
| Total Funding | AUD30.1m | ||
Related Content
Recent News about Kereos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.